Serum Institute applies to DCGI to manufacture Covid-19 vaccine Sputnik V in India
The Serum Institute of India (SII) has applied to the DCGI seeking permission to manufacture Russia s Covid-19 vaccine Sputnik V in India, government sources said.
advertisement
Russia s Sputnik V vaccine has been given approval in India (Reuters)
Pune-based Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture Covid-19 vaccine Sputnik V in the country, government sources said on Thursday. The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the Covid-19 vaccine, Sputnik V, in India, a source said.
COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India
Pune-based Serum Institute has also sought approval for test analysis and examination. Sputnik V is currently being manufactured by Dr Reddy s Lab. India s Serum Institute seeks approval from DCGI to make Russia s Sputnik V vaccine (Image Source: Reuters)
Share
Updated: Jun 3, 2021, 03:35 PM IST
Pune-based Serum Institute of India (SII), the manufacturer of the Covishield vaccine has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday.
The Pune-based vaccine manufacturing firm has also sought approval for test analysis and examination. The SII is currently manufacturing the Covishield doses and the Novavax vaccines.
View from India: 2-DG, India s first anti-Covid drug, coming to hospitals theiet.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theiet.org Daily Mail and Mail on Sunday newspapers.